Ternary Therapeutics targets “undruggable” proteins with AI-designed molecular glues, raising €4.1 million | EU-Startups

London-based BioTech startup Ternary Therapeutics has raised €4.1 million (£3.6 million) in Seed funding to scale an AI platform designed to create a new class of medicines known as molecular glues. The round was led by European venture firm daphni, with participation from Pace Ventures, the i&i Biotech Fund and the UK Innovation & Science […] The post Ternary Therapeutics targets “undruggable” proteins with AI-designed molecular glues, raising €4.1 million appeared first on EU-Startups.